BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 4833844)

  • 1. Factor XIII consumption as an indicator of thrombin generation.
    Triantaphyllopoulos DC
    J Lab Clin Med; 1974 Jul; 84(1):74-80. PubMed ID: 4833844
    [No Abstract]   [Full Text] [Related]  

  • 2. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A microtiter plate assay for factor XIII A-chain-fibrin interactions.
    Achyuthan KE; Santiago MA; Greenberg CS
    Anal Biochem; 1994 May; 219(1):43-8. PubMed ID: 8059954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of thrombin cleavage of plasma factor XIII bound to fibrin.
    Greenberg CS; Achyuthan KE; Miraglia CC; Dobson JV
    Ann N Y Acad Sci; 1986; 485():140-3. PubMed ID: 3471145
    [No Abstract]   [Full Text] [Related]  

  • 6. Physiological effects of the plasminolytic derivatives of fibrinogen.
    Triantaphyllopoulos DC
    Prog Clin Biol Res; 1976; 5():121-45. PubMed ID: 9646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 9. The conversion of fibrinogen to fibrin: A brief history of some key events.
    Doolittle RF
    Matrix Biol; 2017 Jul; 60-61():5-7. PubMed ID: 27519977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Disseminated intravascular coagulation].
    Maekawa T
    Rinsho Byori; 1973 Jan; 21(1):24-30. PubMed ID: 4267649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Structure, metabolism and pathophysiological importance of fibrinogen].
    Lepsanovic LJ
    Med Pregl; 1976; 29(5-6):287-94. PubMed ID: 940540
    [No Abstract]   [Full Text] [Related]  

  • 12. Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen.
    Janus TJ; Lewis SD; Lorand L; Shafer JA
    Biochemistry; 1983 Dec; 22(26):6269-72. PubMed ID: 6661434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrin formation and proteolysis during ancrod treatment. Evidence for des-A-profibrin formation and thrombin independent factor XIII activity.
    Dempfle CE; Argiriou S; Alesci S; Kucher K; Müller-Peltzer H; Rübsamen K; Heene DL
    Ann N Y Acad Sci; 2001; 936():210-4. PubMed ID: 11460476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin binding to fibrin is necessary for fibrin polymers to enhance factor XIIIa formation.
    Greenberg CS; Achyuthan KE; Miraglia CC
    Semin Thromb Hemost; 1986 Jul; 12(3):226-7. PubMed ID: 2877494
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of plasma factor XIII binding to fibrin in vitro.
    Greenberg CS; Dobson JV; Miraglia CC
    Blood; 1985 Nov; 66(5):1028-34. PubMed ID: 2413926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The activation of plasma factor XIII with the snake venom enzymes ancrod and batroxobin marajoensis.
    Walter M; Nyman D; Krajnc V; Duckert F
    Thromb Haemost; 1977 Aug; 38(2):438-46. PubMed ID: 579487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degradation of fibrinogen by plasmin: biological effects of the non-dialysable fibrinogen derivatives.
    Triantaphyllopoulos DC; Chandra S
    Thromb Diath Haemorrh Suppl; 1973; 56():113-26. PubMed ID: 4281938
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of the effect of thrombin on macromolecular substrates].
    Sereiskaia AA; Strukova SM
    Dokl Akad Nauk SSSR; 1985; 282(2):481-4. PubMed ID: 4017865
    [No Abstract]   [Full Text] [Related]  

  • 19. [Activation of factor XIII by beta-thrombin].
    Umarova BA; Strukova SM
    Biokhimiia; 1979 Aug; 44(8):1524-9. PubMed ID: 497297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of fibrinogen and Ca2+ on the thrombin-catalyzed proteolytic event that triggers activation of factor XIII.
    Shafer JA; Lewis SD; Janus TJ; Lorand L
    Ann N Y Acad Sci; 1986; 485():134-9. PubMed ID: 3471144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.